In his state of the union address last night, President Trump said reducing prescription drug prices is “one of my greatest priorities.” Among other health care-related comments, Trump said his administration “is committed to fighting the drug epidemic and helping get treatment for those in need.” He also said it is “time to rebuild our crumbling infrastructure,” and called on Congress to produce a bill that generates at least $1.5 trillion for new infrastructure investment. Commenting on the speech, AHA President and CEO Rick Pollack said, “Along with the Administration’s commitment to reversing the tide of drug addiction and addressing the rising costs of prescription drugs, we support the need to address America’s infrastructure. Hospitals and health care should be part of any effort to fix and improve our nation’s infrastructure. Just as America’s infrastructure must be rebuilt, our health care infrastructure must also be revitalized. More specifically, infrastructure investments are needed to help hospitals meet the needs of their communities, strengthen the capacity for emergency preparedness and response, expand the digital infrastructure for health care, and ensure adequate financing mechanisms for hospitals and health systems. We appreciate the Administration’s support for revitalizing advanced refinancing for tax-exempt bonds.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…